Highly Leveraged Biotechnology Companies

Total Debt
Total DebtEfficiencyMarket RiskExp Return
1AMGN Amgen Inc
64.61 B
 0.02 
 1.39 
 0.03 
2ABBV AbbVie Inc
59.38 B
 0.38 
 0.89 
 0.34 
3GILD Gilead Sciences
26.27 B
(0.06)
 1.83 
(0.11)
4HLN Haleon Plc
10.44 B
 0.02 
 1.45 
 0.03 
5GRFS Grifols SA ADR
9.75 B
(0.07)
 5.42 
(0.41)
6BIIB Biogen Inc
7.34 B
(0.05)
 1.70 
(0.08)
7REGN Regeneron Pharmaceuticals
2.7 B
 0.25 
 1.11 
 0.27 
8ALNY Alnylam Pharmaceuticals
2.68 B
(0.05)
 2.61 
(0.14)
9EXAS EXACT Sciences
2.55 B
(0.07)
 2.65 
(0.19)
10BBIO BridgeBio Pharma
1.74 B
 0.07 
 3.87 
 0.25 
11HALO Halozyme Therapeutics
1.5 B
 0.01 
 2.41 
 0.02 
12IONS Ionis Pharmaceuticals
1.45 B
(0.09)
 2.17 
(0.19)
13EBS Emergent Biosolutions
1.41 B
 0.08 
 11.80 
 0.90 
14SRPT Sarepta Therapeutics
1.4 B
 0.22 
 3.26 
 0.71 
15MRNA Moderna
1.24 B
 0.08 
 3.94 
 0.31 
16INSM Insmed Inc
1.2 B
 0.03 
 2.53 
 0.08 
17BMRN Biomarin Pharmaceutical
1.09 B
(0.08)
 1.53 
(0.12)
18BGNE BeiGene
930.18 M
(0.03)
 3.30 
(0.10)
19VRTX Vertex Pharmaceuticals
808.4 M
 0.16 
 2.03 
 0.32 
20ALVO Alvotech
805.1 M
 0.27 
 3.16 
 0.86 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively. In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.